Phase II Study of Satraplatin and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer: A Pharmacogenetic Assessment of Outcome and Toxicity

Genetic polymorphisms in DNA repair enzymes (excision repair cross-complementing group 1 [ERCC1] and x-ray cross-complementing group 1 [XRCC1]) may predict treatment outcome and response to platinum-based treatment. Twenty-four patients were enrolled in this single-arm study to assess the associatio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Figg, William D., Chau, Cindy H., Madan, Ravi A., Gulley, James L., Gao, Rui, Sissung, Tristan M., Spencer, Shawn, Beatson, Melony, Aragon-Ching, Jeanny, Steinberg, Seth M., Dahut, William L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3758779/
https://ncbi.nlm.nih.gov/pubmed/23684781
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2013.04.007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados